Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?
Dolores J
DJ
Schendel
D000818:Animals; D016326:Extracellular Matrix Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors / Q000276:immunology*; D015470:Leukemia, Myeloid, Acute / Q000276:immunology*; D008297:Male
D016326:Extracellular Matrix Proteins; D018960:Hyaluronan Receptors; C098946:hyaluronan-mediated motility receptor